Callan Hayley E, Jenkins Rosalind E, Maggs James L, Lavergne Sidonie N, Clarke Stephen E, Naisbitt Dean J, Park B Kevin
MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, School of Biomedical Sciences, The University of Liverpool, Liverpool L69 3GE, United Kingdom.
Chem Res Toxicol. 2009 May;22(5):937-48. doi: 10.1021/tx900034r.
Sulfamethoxazole (SMX) induces immunoallergic reactions that are thought to be a result of intracellular protein haptenation by its nitroso metabolite (SMX-NO mass, 267 amu). SMX-NO reacts with protein thiols in vitro, but the conjugates have not been defined chemically. The reactions of SMX-NO with glutathione (GSH), a synthetic peptide (DS3), and two model proteins, human GSH S-transferase pi (GSTP) and serum albumin (HSA), were investigated by mass spectrometry. SMX-NO formed a semimercaptal (N-hydroxysulfenamide) conjugate with GSH that rearranged rapidly (1-5 min) to a sulfinamide. Reaction of SMX-NO with DS3 also yielded a sulfinamide adduct (mass increment, 267 amu) on the cysteine residue. GSTP was exclusively modified at the reactive Cys47 by SMX-NO and exhibited mass increments of 267, 283, and 299 amu, indicative of sulfinamide, N-hydroxysulfinamide, and N-hydroxysulfonamide adducts, respectively. HSA was modified at Cys34, forming only the N-hydroxysulfinamide adduct. HSA modification by SMX-NO under these conditions was confirmed with ELISA and immunoblotting with an antisulfonamide antibody. It is proposed that cysteine-linked N-hydroxysulfinamide and N-hydroxysulfonamide adducts of SMX are formed via the reaction of SMX-NO with cysteinyl sulfoxy acids. Evidence for a multistep assembly of model sulfonamide epitopes on GSH and polypeptides via hydrolyzable intermediates is also presented. In summary, novel, complex, and metastable haptenic structures have been identified on proteins exposed in vitro to the nitroso metabolite of SMX.
磺胺甲恶唑(SMX)可引发免疫过敏反应,人们认为这是其亚硝基代谢产物(SMX-NO质量,267原子质量单位)导致细胞内蛋白质半抗原化的结果。SMX-NO在体外与蛋白质硫醇发生反应,但其共轭物尚未通过化学方法确定。通过质谱研究了SMX-NO与谷胱甘肽(GSH)、一种合成肽(DS3)以及两种模型蛋白,即人谷胱甘肽S-转移酶pi(GSTP)和血清白蛋白(HSA)的反应。SMX-NO与GSH形成了一种半硫醇(N-羟基亚磺酰胺)共轭物,该共轭物迅速(1-5分钟)重排为亚磺酰胺。SMX-NO与DS3的反应在半胱氨酸残基上也产生了一种亚磺酰胺加合物(质量增加267原子质量单位)。GSTP仅在反应性Cys47处被SMX-NO修饰,质量增加分别为267、283和299原子质量单位,分别表明为亚磺酰胺、N-羟基亚磺酰胺和N-羟基磺酰胺加合物。HSA在Cys34处被修饰,仅形成N-羟基亚磺酰胺加合物。在这些条件下,通过酶联免疫吸附测定(ELISA)和用抗磺酰胺抗体进行免疫印迹证实了SMX-NO对HSA的修饰。有人提出,SMX的半胱氨酸连接的N-羟基亚磺酰胺和N-羟基磺酰胺加合物是通过SMX-NO与半胱氨酰亚磺酸的反应形成的。还提供了通过可水解中间体在GSH和多肽上多步组装模型磺酰胺表位的证据。总之,在体外暴露于SMX亚硝基代谢产物的蛋白质上已鉴定出新型、复杂且亚稳的半抗原结构。